BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korzenik JR. IBD: A vascular disorder? the case for heparin therapy. Inflamm Bowel Dis 1997;3:87-94. [DOI: 10.1002/ibd.3780030205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Sands BE. Therapy of inflammatory bowel disease. Gastroenterology. 2000;118:S68-S82. [PMID: 10868899 DOI: 10.1016/s0016-5085(00)70007-2] [Cited by in Crossref: 165] [Cited by in F6Publishing: 31] [Article Influence: 7.9] [Reference Citation Analysis]
2 Sands BE. Novel therapies for inflammatory bowel disease. Gastroenterol Clin North Am 1999;28:323-51. [PMID: 10372271 DOI: 10.1016/s0889-8553(05)70059-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stein RB, Hanauer SB. MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 1999;28:297-321. [DOI: 10.1016/s0889-8553(05)70058-3] [Cited by in Crossref: 64] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
4 Vrij AA, Oberndorff-klein-woolthuis A, Dijkstra G, de Jong AE, Wagenvoord R, Hemker HC, Stockbrügger RW. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis 2007;24:175-82. [DOI: 10.1007/s11239-006-9046-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]